Back to News
Market Impact: 0.1
You May Be Entitled to a Cash Payment From a Class Action Settlement if You Performed a Skin360® Skin Assessment Using Any Version of Skin360®, Including Neutrogena® Skin360®, NeoStrata® Skin360®, and Any Skin360®Collaborations With Other Entities, While in Illinois Through a Mobile Application or Web Application, Between December 9, 2019 and May 5, 2023
Source: PR Newswire
Legal & LitigationHealthcare & Biotech
A court-approved settlement notice was issued in the U.S. District Court for the District of New Jersey case Helene Melzer, et al. v. Johnson & Johnson Consumer Inc. The excerpt provides no settlement amount, allegations, financial impact, or operational implications, limiting its relevance for investors.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment
JNJ-0.40
More News
- J&J's potential 'game-changer' drug — plus, what Microsoft's mass buyouts mean
- Johnson & Johnson’s prostate cancer drug shrinks tumors in early-stage trial
- ‘Imposed significant financial harm’: 20 states join the FTC in suing Dollar General for ‘deceptive pricing practices’ despite ‘corporate knowledge’
- The excitement around Moderna’s cancer vaccine is cooling. Here’s why.
- Anthropic’s dual-class share structure borrows ideas from Mark Zuckerberg, Elon Musk—and the New York Times
- Cramer: I asked some tech insiders what to buy. They surprisingly said this drug stock